Family Medicine · Jamaica, NY
NPI
1760619993
Since 2009
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
16121 Jamaica Ave Ste 7
Jamaica, NY, 11432
Phone (929) 421-4630
Groups this clinician bills Medicare through
Medicare paid, 2023
$1,080
15 services
Medicare patients, 2023
12
Average age 62
Drug cost, 2024
$5.9M
5,046 prescriptions
Company payments, 2025
$12K
From 5 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Nonglin Mel was code 99214 (office e&m - established), 13 times for 11 patients. In total Nonglin Mel billed 15 services in 3 codes, and Medicare paid $1,080.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 13 | 11 | $79.01 | $1,027 |
By year: 2022 $2,145 for 40 services; 2023 $1,080 for 15 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nonglin Mel prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 603 prescriptions and refills. In total Nonglin Mel wrote 5,046 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 603 | 603 | 97 | $2.3M |
| Atorvastatin Calcium Generic | 302 | 653 | 90 | $2,011 |
| Amlodipine Besylate Generic | 246 | 482 | 66 | $723 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 190 | 200 | 28 | $905K |
| Lisinopril Generic | 162 | 278 | 40 | $593 |
| Descovy Emtricitabine/Tenofov Alafenam | 158 | 158 | 22 | $333K |
| Tivicay Dolutegravir Sodium | 136 | 136 | 20 | $332K |
| Losartan Potassium Generic | 124 | 255 | 36 | $1,095 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 109 | 153 | 30 | $4,031 |
| Gabapentin Generic | 101 | 198 | 27 | $1,378 |
| Juluca Dolutegravir/Rilpivirine | 96 | 96 | 13 | $328K |
| Rybelsus Semaglutide | 90 | 120 | 14 | $110K |
| Jardiance Empagliflozin | 87 | 125 | 14 | $73K |
| Rosuvastatin Calcium Generic | 78 | 178 | 23 | $579 |
| Trazodone Hcl Generic | 74 | 147 | 24 | $281 |
Brand drugs: 2,157 claims; generic drugs: 2,843 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nonglin Mel $12K ($12K in general payments such as food, travel and fees) from 5 companies. The largest payer was Gilead Sciences, Inc. with $11K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.